eXoZymes Inc. Common Stock (EXOZ)
Stock · NASDAQ · Health Care
$4.09as of 10/16/2026
Price chart
Active signals
EXOZ Signal Track Record
How signals performed across all stocks →What EXOZ's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band Breakdown | 3 | -19.0% | 0% | October 5, 2026 |
| Bollinger Band Breakout | 4 | +12.7% | 100% | August 17, 2026 |
| 200-Day Moving Average TouchActive now | 3 | +21.1% | 67% | December 16, 2025 |
| Any 20-session window (baseline) | -9.2% | 33% |
Computed by MarketWall from daily closing prices since September 3, 2025. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About EXOZ
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Employees
- 32
- Website
- exozymes.com/
Fundamentals
- 1-day range
- $3.71$4.88
- Market cap
- $47.57M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- $-1.20
- Dividend yield
- —
- Beta
- 1.26
- Avg. volume
- 7.0K
eXoZymes Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- EXOZeXoZymes Inc. Common Stock$4.09▲ 2.25%Market cap $47.57MP/E —$4.35$18.4
- MGXMetagenomi Therapeutics Inc. Common Stock$0.784▼ 7.22%Market cap $46.68MP/E —$0.86$3.95
- ATYRaTyr Pharma Inc. Common Stock$0.174▼ 5.43%Market cap $49.22MP/E —$0.2$1.11
- TILInstil Bio Inc. Common Stock$5.91▼ 3.59%Market cap $49.37MP/E —$5.67$21.64
- TCRXTScan Therapeutics Inc. Common Stock$0.231▼ 3.35%Market cap $49.88MP/E —$0.2243$2.57
- INMBINmune Bio Inc. Common stock$1.57▼ 4.85%Market cap $50.78MP/E —$1.09$2.6
- OKYOOKYO Pharma Limited Ordinary Shares$1.41▼ 1.40%Market cap $51.94MP/E —$1.26$3.2
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| EXOZ eXoZymes Inc. Common Stock | $47.57M | — | $4.09 | ▲ 2.25% | $4.35$18.4 |
| MGX Metagenomi Therapeutics Inc. Common Stock | $46.68M | — | $0.784 | ▼ 7.22% | $0.86$3.95 |
| ATYR aTyr Pharma Inc. Common Stock | $49.22M | — | $0.174 | ▼ 5.43% | $0.2$1.11 |
| TIL Instil Bio Inc. Common Stock | $49.37M | — | $5.91 | ▼ 3.59% | $5.67$21.64 |
| TCRX TScan Therapeutics Inc. Common Stock | $49.88M | — | $0.231 | ▼ 3.35% | $0.2243$2.57 |
| INMB INmune Bio Inc. Common stock | $50.78M | — | $1.57 | ▼ 4.85% | $1.09$2.6 |
| OKYO OKYO Pharma Limited Ordinary Shares | $51.94M | — | $1.41 | ▼ 1.40% | $1.26$3.2 |
P/E shows — for peers not currently carrying a live signal of their own.
Insider Activity
Insider Actions →- Nawaz Fouad · September 14, 2026 · Grant45.0K
- Heltzen Michael · August 26, 2026 · Buy250 @ $7.6
- Heltzen Michael · August 26, 2026 · Buy251 @ $7.35
- Heltzen Michael · August 26, 2026 · Buy4 @ $7.58
- Heltzen Michael · August 25, 2026 · Buy100 @ $7.5
- Heltzen Michael · August 25, 2026 · Buy250 @ $7.52
- Heltzen Michael · August 19, 2026 · Grant8.8K @ $6.4
- Perriman Damien Alan · August 19, 2026 · Option Exercise19.6K
- Korman Tyler Paz · August 19, 2026 · Option Exercise33.0K
Institutional Ownership
March 31, 2026
- Total shares held
- 53.5K
- Total value held
- $401.1K
- Institutional holders
- 6
- Unknown22.2K
- Unknown21.9K
- Unknown6.8K
- Unknown1.3K
- Unknown1.3K
- Unknown24
See the full, filterable feed with live charts on the MarketWall dashboard.